NAI for Sepsis With Persistent Lymphopenia

Clinical trial NCT07578558 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07578558
Sponsor: ImmunityBio, Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Sepsis Septic Shock Lymphopenia Immunosuppression Critical Illness

Start date: 2026-07-06
Primary completion: 2027-08-03
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.